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304a Monday, February 27, 2012interest for its effects on the physical properties of biological membranes. In
model membrane studies ceramide has been shown to promote phase separation
and domain formation, non-lamellar phases, and enhanced membrane perme-
ability. We recently reported the synthesis and photochemical characterization
of long-chain ceramides caged with a 6-bromo-7-hydroxycoumarin group.
These derivatives were readily dispersed in aqueous solution, successfully de-
livered into cells and uncaged therein. Caged compounds such as these can be
released in their biologically active form with a high degree of spatial and tem-
poral control. These characteristics are attractive in applications where well-
defined amounts of ceramide must be generated. Previous work has largely re-
lied on exogenous delivery of synthetic short-chain ceramides or sphingomye-
linase treatments where enzyme activity can be difficult to control. Further
studies are currently under way in HL-60 cells using the caged compounds
to probe the role of long-chain ceramides in pro-apoptotic pathways. Concur-
rently, we have incorporated caged ceramides into supported lipid bilayers as
part of ongoing work to model ceramide’s mechanical and morphological ef-
fects in membranes.
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Ryanodine Receptors (RyRs) are intracellular calcium-release channels acting
as one of the key regulatory elements in the excitation-contraction coupling.
More than 350 mutations have been found in RyRs that are known to underlie
severe genetic diseases. Mutations in the skeletal muscle isoform (RyR1) are
associated with malignant hyperthermia (MH) and central core disease
(CCD), while mutations in the cardiac isoform (RyR2) cause catecholaminer-
gic polymorphic ventricular tachycardia (CPVT) and arrhythmogenic right
ventricular dysplasia (ARVD). Most mutations confer a gain of function, but
the precise mechanisms that explain enhanced channel opening up to the mo-
lecular scale have remained elusive. Here we present pseudo-atomic models
of the N-terminal disease hot spot in the open and closed states of the RyR,
along with crystal structures of several disease mutants. The data show that
the intersubunit interfaces formed by tetrameric N-terminal disease hot spots
are disrupted upon channel opening in wild-type RyRs. This intersubunit inter-
face harbors 19 disease mutations, the largest cluster within the N-terminal re-
gion, indicating the vulnerability of this interface in channel regulation. We
present crystal structures and thermal stabilities of nine disease mutants located
at other interfaces. The effect of most mutations are destabilizing to the protein,
with decreases in melting temperatures as large as ~10C. Buried disease mu-
tations cause structural changes to the intersubunit interface, while mutations
affecting ionic pairing at the intra-subunit interface significantly alter relative
domain orientations. Mutations far away from the intersubunit interface can
thus affect these contacts via long-range conformational changes. These results
illuminate the intersubunit interface between N-terminal disease hot spots as
a prime target for disease mutations through direct or indirect conformational
changes.
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The amino-terminal region of both the skeletal and cardiac ryanodine receptor
is a disease mutation hotspot. Previously, a crystal structure of a RyR1 frag-
ment (amino acids 1-559) was solved and folded into three separate structural
domains, A, B and C. Docking of the modeled fragment into a cryo-EMmap of
the full-length RyR1 has placed the ABC domains in a central vestibule in the
cytoplasmic assembly. In the present study, we constructed a full-length RyR2-
GFP chimera, with GFP inserted after residue Glu-310. The cryo-EM structure
of RyR2E310-GFP clearly showed an extra mass in the domain B, which directly
confirms the docking model. To probe the conformational changes in the N-ter-minal region of the channel, we generated three FRET pairs by inserting CFP or
YFP after residues His-29, Glu-310, or Lys-441. Conformational dynamics
inside the N-terminal region were analyzed using three dual-insertion pairs
(RyR2H29-CFP/E310-YFP, RyR2H29-CFP/Y441-YFP, and RyR2E310-YFP/K441-CFP) as
well as in three co-expression single-insertion pairs (RyR2H29-CFP/RyR2E310-
YFP, RyR2H29-CFP/RyR2Y441-YFP, and RyR2E310-YFP/RyR2K441-CFP). Our results
indicated that upon RyR channel activation by caffeine, domains B and C move
apart, whereas distances between domains A and B, and between A and C are
almost unchanged inside one subunit of RyR. One other note of interest is that
domain A moves away from both domains B and C in the neighboring subunits;
meanwhile the distance between domains B and C from two neighboring sub-
units remains unchanged.
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The type 1 ryanodine receptor (RyR1) is a Ca2þ release channel found in the
sarcoplasmic reticulum of skeletal muscle and plays a pivotal role in
excitation-contraction coupling. The RyR1 channel is activated by a conforma-
tional change of the dihydropyridine receptor upon depolarization of the trans-
verse tubule, or by Ca2þ itself, i.e., Ca2þ-induced Ca2þ release (CICR). The
molecular events transmitting such signals to the ion gate of the channel are un-
known. The S4-S5 linker, a cytosolic loop connecting the S4 and S5 transmem-
brane segments in six-transmembrane type channels, forms a-helical structure
and mediates signal transmission in a wide variety of channels. To address the
role of S4-S5 linker in the RyR1 channel gating, we performed alanine substi-
tution scan of amino (N)-terminal half of the putative S4-S5 linker (Thr4825-
Ser4829) that exhibits high helix probability. The mutant RyR1 was expressed
in HEK cells and the CICR activity was investigated by caffeine-induced
Ca2þ release, single-channel current recordings, and [3H]ryanodine binding.
Four mutants (T4825A, I4826A, S4828A and S4829A) had reduced CICR ac-
tivity without changing the Ca2þ sensitivity, whereas the L4827A mutant
formed a constitutive active channel. T4825I, a disease-associated mutation
for malignant hyperthermia, exhibited enhanced CICR activity. An a-helical
wheel representation of the N-terminal S4-S5 linker provides a rational expla-
nation to the observed activities of the mutants. These results suggest that N-
terminal half of the S4-S5 linker may form a-helical structure and play an
important role in the RyR1 channel gating.
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The cardiac ryanodine receptor (RyR2) mediates the release of calcium from
the sarcoplasmic reticulum of cardiac myocytes. The functional channel is
composed of four identical subunits with the C-terminal part comprising the
transmembrane domain predicted to form the Ca2þ-conducting pore. The large
N-terminal cytoplasmic portion of RyR2 is believed to serve as a scaffold for
interaction with accessory proteins, ions and other regulatory molecules.
RyR2 channel gating is regulated by a complex network of inter- and intra-
subunit interactions between discrete structural domains. It has been proposed
that disruption of inter-domain cross-talk results in abnormal RyR2 channel
function, as observed in catecholaminergic polymorphic ventricular tachycar-
dia (CPVT) and heart failure.
Here, we report that the RyR2 amino-terminus, containing one of the three
CPVT-associated mutation hot spots, is capable of self-association. Chemical
cross-linking of an RyR2 N-terminal fragment (BT4L; residues 1-906) indi-
cated that it can assemble into tetramers. Moreover, BT4L expressed in mam-
malian HEK293 cells was found to form tetramers through endogenous
disulphide bonds. We undertook a site-directed mutagenesis approach to
identify the cysteines involved in BT4L disulphide bond formation, whereby
cysteine residues were substituted by serine. The BT4L Cys361 Ser mutant
did not form DTT-sensitive tetramers, suggesting that Cys361 participates
in disulphide bond formation. When BT4L was co-expressed with full-
length RyR2 in HEK293 cells it translocated from the cytosol to the
